您的位置:网站名称 研发专利新闻 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

USPTO issues Notice of Allowance to Modular's green surfactant patent application


Modular Genetics, Inc. (Modular) is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.

The U.S. Patent and Trademark Office has issued a Notice of Allowance allowing patent claims that protect Modular's "green" surfactant, a myristoyl glutamate. Independent testing by Columbia University has demonstrated Modular's surfactant is ten-fold more effective at reducing surface tension and three times more water soluble than the leading marketed product; two important qualities for a superior, cost competitive cleansing product.

According to Kevin Jarrell, Modular's CEO and co-founder, "The Company's strategy is to invent, develop and commercialize high value specialty chemicals that are patent protected. The same core proprietary technology is being used to generate a family of patented "green surfactants". Modular's surfactants will be used in products as diverse as shampoos and paints and coatings." Modular is in partnering discussions with leading chemical companies to commercialize these surfactants.

Dr. Fangli Chen, partner in the Intellectual Property Department at Choate, Hall & Stewart, LLP confirms that this allowed patent provides excellent protection for Modular's product, and solidifies its position as a leader in the green chemicals marketplace. Dr. Chen offers that "The allowed composition claims will provide strong protection for Modular's unique product and create effective barriers to competitors in the surfactant market."

Brent Erickson, Executive Vice President, Industrial and Environmental Section, the Biotechnology Industry Organization (BIO), offers this perspective: "Biotechnology companies in the green chemistry space historically focused on fuels and green plastics followed by a shift to commodity chemicals. Today, there is a new emphasis on specialty chemicals because of the higher margins these products command, combined with the opportunity to create value by securing patent protection for the end chemical products themselves. The demonstrated ability of "synthetic biology" companies to commercialize patented specialty chemicals should provide confidence to investors and attract further investment to this sector of the Cleantech economy. " In addition, McKinsey Consulting estimates that 50,000 organic chemicals produced from petroleum can be made from renewable feedstocks, over a $1 trillion market.

Source: Modular

模块化遗传学公司(模块制)是一种可持续利用的化学公司合成生物学的先进技术,生产的特色食品,具有成本竞争力,提供优越的性能和对环境友好的化学品。模块化的主导产品是“绿色”表面活性剂最初的目标的个人护理市场。

美国专利和商标局发出的津贴公告称,允许专利保护模块化的“绿色”表面活性剂,一个豆蔻谷氨酸。由哥伦比亚大学的独立测试表明模块化的表面活性剂是十倍,更有效地降低表面张力和水的三倍多比领先销售产品不溶于水的优越,成本竞争力的洁面产品两个重要的素质。

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

Biotectix acquires Chameleon BioSurfaces
U.S. District Court rules in favor of Wa
US District Court rules against Watson i
USPTO issues Notice of Allowance to Alph
VARI, Gentel Biosciences receive U.S. Pa
Colorcon announces specific details on i
ACT to be awarded broad patent protectio
NephRx receives new U.S. patent for NX00
USPTO grants patent to ULURU's Altrazeal
NephRx receives new U.S. patent for NX00
USPTO issues patent to Somaxon's Silenor
USPTO grants composition-of-matter paten
USPTO issues patent to Asterand's BioMAP
Medical industry veteran set to play key
Cubist enters license agreement with Tev
Shire files lawsuit against Watson over
USPTO issues notice of allowance to Mirn
EPO Board of Appeal rejects B.Braun pate
Watson confirms patent challenge by Alco
USPTO issues new patent to Onset Medical

相关评论


本文章所属分类:首页 研发专利新闻